ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Describes Peer Review Process

July 12, 1996

Pressure On Reagan To Appoint Scientists to NCAB Increases with Demand From Powerful Congressman

March 9, 1984

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978